Burrage Capital is a long short equity fund focused in health care. The firm was launched in 2011 with flagship investor Foxconn Technologies. Burrage Capital uses in-depth medical and industry research to identify undervalued companies which are developing compelling drugs, medical technologies, research tools, and diagnostics. The investment process at Burrage Capital is driven by deep industry research and insight. The first step is the identification of quality scientific and clinical assets. Next steps include diligence through an established network of medical, regulatory and commercial industry leaders. Investments are then made opportunistically when there is a compelling risk / reward. Burrage Capital investments are run by top tier management teams with outstanding scientific, clinical, regulatory and financial experience.
View Top Employees from Burrage Capital ManagementWebsite | http://www.burragecapital.com |
Revenue | $5 million |
Employees | 2 (2 on RocketReach) |
Founded | 2011 |
Address | 314 Commonwealth Ave, Boston, Massachusetts, US |
Phone | (617) 410-4770 |
Technologies |
HTML,
PHP,
Twitter
+5 more
(view full list)
|
Industry | Financial Services, Finance General, Finance |
SIC | SIC Code 67 Companies, SIC Code 679 Companies |
NAICS | NAICS Code 523 Companies, NAICS Code 5239 Companies, NAICS Code 52 Companies |
Looking for a particular Burrage Capital Management employee's phone or email?
The Burrage Capital Management annual revenue was $5 million in 2024.
2 people are employed at Burrage Capital Management.
Burrage Capital Management is based in Boston, Massachusetts.
The NAICS codes for Burrage Capital Management are [523, 5239, 52].
The SIC codes for Burrage Capital Management are [67, 679].